跳至主要内容
临床试验/NCT01389791
NCT01389791Unknown不适用

MgSO4 Combined With Rocuronium Priming

Seoul National University Bundang Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2011年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
100
试验地点
1
主要终点
time from injection of induction dose of rocuronium until 95% depression of TOF

研究概览

简要总结

Priming with either rocuronium or MgSO4 is known to accelerate the effect of rocuronium on muscle relaxation. The purpose of this study is to define the effect of MgSO4 on the rocuronium-priming.

详细描述

Acceleration of muscle relaxation is beneficial in rapid-sequence intubation. If MgSO4 combined with priming is efficient in accelerating muscle relaxation, it would be an interesting alternative to rapid-sequence intubation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients of ASA Ⅰ-Ⅱ
  • aged 18~65
  • scheduled to undergo elective surgery under general anesthesia

排除标准

  • risk of pulmonary aspiration
  • anticipated airway difficulty
  • reactive airway disease
  • allergic to study drugs
  • neuromuscular / cardiovascular/ renal/ hepatic disease
  • atrioventricular conduction disturbance
  • BMI < 18.5 or > 24.9
  • chronic treatment with calcium channel blocker
  • medications which affect muscle relaxation

研究组 & 干预措施

priming

Active Comparator

patients in this group receive 0.06mg/kg of rocuronium before 0.54mg/kg of rocuronium.

干预措施: priming (Drug)

Mg&priming

Experimental

Patients in this group receive MgSO4 50mg/kg and 0.06mg/kg of rocuronium before administration of 0.54mg/kg of rocuronium.

干预措施: magnesium sulfate and priming (Drug)

MgSO4

Active Comparator

Patients in this group receive intravenous MgSO4 before administration of rocuronium.

干预措施: magnesium sulfate (Drug)

结局指标

主要结局

time from injection of induction dose of rocuronium until 95% depression of TOF

时间窗: time from injection of induction dose of rocuronium until 95% depression of TOF, upto 5 min

次要结局

  • rocuronium duration(time from injection of induction dose of rocuronium until train-of-four count reaches two.)
  • intubating condition(time from injection of induction dose of rocuronium until tracheal intubation.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kim Mihyun

full instructor

Seoul National University Bundang Hospital

研究点 (1)

Loading locations...

相似试验